New Insights into the PPARγ Agonists for the Treatment of Diabetic Nephropathy

Diabetic nephropathy (DN) is a severe complication of diabetes and serves as the leading cause of chronic renal failure. In the past decades, angiotensin-converting enzyme inhibitors (ACEIs)/angiotensin II receptor blockers (ARBs) based first-line therapy can slow but cannot stop the progression of...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Jia, Zhanjun, Sun, Ying, Yang, Guangrui, Zhang, Aihua, Huang, Songming, Heiney, Kristina Marie, Zhang, Yue
Format: Artigo
Idioma:Inglês
Publicat: Hindawi Publishing Corporation 2014
Matèries:
Review Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3927865/
https://ncbi.nlm.nih.gov/pubmed/24624137
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2014/818530
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars